Maxam Nutraceutics Announces Support For Autism Awareness Month

Feb. 25, 2010 - PRLog -- HOOD RIVER, OR, (February 24, 2010) – To raise public awareness and concern for the epidemic growth rate of autism in the U.S., which has reached 1 in 110 children, according to the Center for Disease Control (CDC), the Autism Society of America has designated April as National Autism Awareness Month. To support this initiative, Maxam Nutraceutics – the company who researched and developed PCA-Rx, a natural toxin-removal and autism treatment method - announced today it would start donating proceeds of its product sales sold through www.maxamlabs.com to several autism organizations as chosen by its customers through April 30.

“At Maxam Nutraceutics, we have been dedicated for more than 20 years to ending autism", explained President James Cole. “We are thrilled to participate in this initiative, not only to offer those with autism a natural, toxin removal treatment, but to provide autism organizations with much needed funds to continue research and support.”

While controversy looms regarding autism’s cause, many parents of autistic children believe a correlation exists with toxin accumulation. Until recently, chelation, an invasive, drug-based toxin removal therapy, has been parents’ primary option. PCA-Rx is the result of years of rigorous research and development. According to Cole, it represents a breakthrough in toxin removal technology called Clathration Therapy. This epigenetic cell fermentation formula is comprised of helpful bacteria and other microbes that when used become a natural, living part of the body's immune system. When administered orally one to eight sprays per day under the tongue, it envelops, neutralizes and removes the harmful toxins through stool, urine, skin and breath, without ever touching vital organs or tissue.

PCA-Rx helps to eliminate heavy metals, chemical toxins and harmful parasite microorganisms; reduce cardio and cerebral vascular plaque; lower elevated enzyme counts; and decrease environmental illness effects.
PCA Rx is also used for Alzheimer’s, candida, cervical dystonia, chemical exposure, heart disease, hepatitis, herpes, Lyme disease, paralysis, Niemann-Pick disease and uterine fibroids. It is available through www.maxamlabs.com.

About the Autism Society of America (ASA)
Created in 1996 to address the need for expanded research of autism spectrum disorders, the ASA Foundation supports scientists' goals to understand everything related to autism. The ASA Foundation supports both applied research and studies looking into the biomedical approaches to autism.

With its strong history, the Autism Society of America is in position to continue to be the leading autism organization in the United States for years to come. The Autism Society of America is there to provide all affected by autism with support and information. For more information, visit http://www.autism-society.org/.

For more information, or interview scheduling with James Cole, contact Renee Cooper of ChristieCommunications at (805) 962-1347 or rcooper@christiecomm.com.


*PCA Rx has not been evaluated by the FDA and not intended to diagnose, treat, or cure any disease.